• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Compound K

CAS No. 160729-91-9

Compound K ( 人参皂苷CK )

产品货号. M39818 CAS No. 160729-91-9

L 754394 is an effective and specific inhibitor of the HIV-1 protease.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
25MG 获取报价 有现货
50MG ¥27360 有现货
100MG 获取报价 有现货

生物学信息

  • 产品名称
    Compound K
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    L 754394 is an effective and specific inhibitor of the HIV-1 protease.
  • 产品描述
    HIV-IN-11 is part of the hydroxylaminoglutaramide (HAPA) transition state isomeric series of HIV protease inhibitors and is a potent and selective inhibitor of HIV-1 protease. HIV-IN-11 competitively inhibits HIV-1 PR (Ki: 0.049 nM) and potently inhibits replication of HIV(IIIb)-infected MT4 lymphocytes at concentrations of 25.0-50.0 nM. HIV-IN-11 displays a longer half-life than indinavir sulfate in animal models and serves as a promising second-generation HIV protease inhibitor.
  • 体外实验
    ———
  • 体内实验
    ———
  • 同义词
    人参皂苷CK
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    ———
  • 研究领域
    ———
  • 适应症
    ———

化学信息

  • CAS Number
    160729-91-9
  • 分子量
    653.81
  • 分子式
    C38H47N5O5
  • 纯度
    >98% (HPLC)
  • 溶解度
    ———
  • SMILES
    ———
  • 化学全称
    ———

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Dorsey BD, et al. Identification of MK-944a: a second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitors. J Med Chem. 2000 Sep 7;43(18):3386-99.?
产品手册
关联产品
  • Ezatiostat hydrochlo...

    Ezatiostat 盐酸盐是一种有效的谷胱甘肽 S-转移酶抑制剂。 Ezatiostat 盐酸盐是一种新型谷胱甘肽类似物,是治疗血细胞减少症的潜在化合物。

  • Prolyl-4-hydroxylase...

    Prolyl-4-hydroxylase Inhibitor 11, a novel proline 4-hydroxylase inhibitor, shows protective effects against oxidative stress and Cu(II) toxicity in Chlorella vulgaris.

  • TG-2-IN-1

    TG-2-IN-1 is a potent transglutaminase-2 (TGM-2) inhibitor.TG-2-IN-1 is used in the study of cancer, neurological disorders, and immune system disorders.